Login
Home / BYSI : NASDAQ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BeyondSpring Inc.

$0.78 -$0.83 (-51.56%)
NASDAQ · 15 Sep 2026 15:07 UTC
Previous Close
$0.76
Day Range
$0.74$0.8
Year Range
$0.57$2.44
Market Cap
32.07M
AVG Volume
23.68K
Trailing/Forward PE
-4.6/0.39
PEG ratio
-0.06
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Revenue (USD)
-1M-500K0500K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (USD)
-5M-2.5M02.5M5M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (USD)
-4M-2M02M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (USD)
-4M-2M02M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (USD)
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (USD)
-0.2-0.100.10.224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (USD)
-2M02M4M6MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (USD)
05M10M15MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
00.511.5224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%50%100%150%22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
Return on Capital
-40%-20%0%20%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Book Value Per Share (USD)
-1-0.75-0.5-0.25024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (USD)
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Employee Count
02550751002016201720182019202020212022202320242025
Free Cash Flow Yield
-80%-60%-40%-20%0%med -14.58%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
-400-2000200med 38.05Dec 23Apr 24Jul 24Nov 24Feb 25Jul 25Nov 25
Price/Operating Cashflow
050100150200med 46.74May 23Jul 23Sep 23Nov 23Jan 24Mar 24Apr 24
Price to Book
05101520med 4.54Apr 21Aug 21Nov 21Mar 22Jun 22Sep 22Apr 23
BeyondSpring Inc.
BYSI
Stockpicker

Video analysis: BYSI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BYSI

BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update

globenewswire.com · 14 Aug 2026

BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update

ASCO 2026 Data Demonstrate Long-term Survival Benefit of Plinabulin/Docetaxel and Pembrolizumab in Metastatic NSCLC Following Progression on First-Line Immune Checkpoint Inhibitor (ICI) Therapy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.